Clinical Trials Directory

Trials / Completed

CompletedNCT02362776

Metabolic Changes as a Diagnostic Indicator for Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
426 (actual)
Sponsor
Hasselt University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This study aims to determine whether metabolic changes occur in blood plasma of cancer patients, and whether these changes can be used as a biomarker to detect cancer. These analyses will be done by means of nuclear magnetic resonance (NMR) spectroscopy.

Conditions

Interventions

TypeNameDescription
OTHERVenous blood sampleCollection of a venous blood sample to investigate metabolic changes in blood

Timeline

Start date
2009-10-01
Primary completion
2012-07-01
Completion
2012-07-01
First posted
2015-02-13
Last updated
2015-02-13

Locations

2 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02362776. Inclusion in this directory is not an endorsement.